Debt to Equity Ratio Chart

View Debt to Equity Ratio for TRVI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 0.0019
March 31, 2026 0.004
December 31, 2025 0.0041
September 30, 2025 0.0043
June 30, 2025 0.0045
March 31, 2025 0.0096
December 31, 2024 0.0104
September 30, 2024 0.0189
June 30, 2024 0.018
March 31, 2024 0.0176
December 31, 2023 0.0162
September 30, 2023 0.0157
June 30, 2023 0.0155
March 31, 2023 0.0886
December 31, 2022 0.0854
September 30, 2022 0.0988
June 30, 2022 0.2069
March 31, 2022 1.367
Date Value
December 31, 2021 0.8634
September 30, 2021 1.289
June 30, 2021 0.8237
March 31, 2021 0.6135
December 31, 2020 0.5281
September 30, 2020 0.4006
June 30, 2020 0.0077
March 31, 2020 0.0071
December 31, 2019 0.0065
September 30, 2019 0.0062
June 30, 2019 0.0059
March 31, 2019 0.0332
December 31, 2018 0.1754
September 30, 2018 0.0796
June 30, 2018
March 31, 2018
December 31, 2017 0.3576

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621